SFX by Ex Libris Inc.

Title:	Preparation and Evaluation of Unimolecular Pentavalent and Hexavalent Antigenic Constructs Targeting Prostate and Breast Cancer: A Synthetic Route to Anticancer Vaccine Candidates
Source:	Journal of the American Chemical Society [0002-7863] Ragupathi, Govind yr:2006

Basic

Full text

Full text available via American Chemical Society Journals

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Niederhafner Petr, P. "Glycopeptide dendrimers. Part II." Journal of peptide science 14.1 (2008): 44-65.
description	2.	Slovin, S. "Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer." Cancer immunology, immunotherapy 54.7 (2005): 694-702.
description	3.	Geng, Xudong D. "In pursuit of carbohydrate-based HIV vaccines, Part 2: The total synthesis of high-mannose-type gp120 fragments-evaluation of strategies directed to maximal convergence." Angewandte Chemie (International ed.) 43.19 (2004): 2562-2565.
description	4.	Spassova, Maria K. "Synthesis of selected Le(Y) and KH-1 analogues: A medicinal chemistry approach to vaccine optimization." Journal of organic chemistry 70.9 (2005): 3383-3395.
description	5.	Mischo, A. "Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer." International journal of cancer 118.3 (2006): 696-703.
description	6.	Niederhafner, P. "Glycopeptide dendrimers. Part I." Journal of peptide science 14.1 (2008): 2-43.
description	7.	Petersson, E. "Toward beta-amino acid proteins: Design, synthesis, and characterization of a fifteen kilodalton beta-peptide tetramer." Journal of the American Chemical Society 130.3 (2008): 821-.
description	8.	Caminade, A. "Characterization of dendrimers." Advanced Drug Delivery Reviews 57.15 (2005): 2130-46.
description	9.	Awad, L. "A C-Linked Disaccharide Analogue of Thomsen-Friedenreich Epitope Induces a Strong Immune Response in Mice." Chemistry - A European Journal 18.28 (2012): 8578-8582.
description	10.	Ragupathi, LJ. "Constructing an adenocarcinoma vaccine: Immunization of mice with synthetic KH-1 nonasaccharide stimulates anti-KH-1 and anti-Le(y) antibodies." International journal of cancer 99.2 (2002): 207-212.
description	11.	Hoffmann Roder, A. "Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue." Angewandte Chemie (International ed. in English) 49.45 (2010): 8498-8503.
description	12.	Weiner, L. "Monoclonal antibodies: versatile platforms for cancer immunotherapy." Nature Reviews. Immunology 10.5 (2010): 317-327.
description	13.	Russo, V. "Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy." International journal of cancer 64.3 (1995): 216-21.
description	14.	Ooi, T. "Hypercoordination of aluminum: evidence for the implication of pentacoordinate complexes in the R2AlCl-promoted reduction of alkoxycarbonyl substrates." Tetrahedron letters; 40.15 (1999): 2993-2996.
description	15.	Keding, Samuel J. "Prospects for total synthesis: A vision for a totally synthetic vaccine targeting epithelial tumors." Proceedings of the National Academy of Sciences of the United States of America 101.33 (2004): 11937-11942.
description	16.	Dudkin, Vadim Y. "Chemical Synthesis of Normal and Transformed PSA Glycopeptides." Journal of the American Chemical Society 126.3 (2004): 736-738.
description	17.	Ragupathi, G. "On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines." Proceedings of the National Academy of Sciences of the United States of America 99.21 (2002): 13699-13704.
description	18.	Young, Scott D D. "Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors." Clinical cancer research 12.10 (2006): 3092-8.
description	19.	Warren, J David D. "Toward fully synthetic glycoproteins by ultimately convergent routes: A solution to a long-standing problem." Journal of the American Chemical Society 126.21 (2004): 6576-6578.
description	20.	Wong, Chi-Huey H. "Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody." Angewandte Chemie (International ed.) 43.8 (2004): 1000-3.